Differences in external price referencing in Europe—A descriptive overview
- 19 October 2011
- journal article
- Published by Elsevier in Health Policy
- Vol. 104 (1) , 50-60
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member StatesCroatian Medical Journal, 2011
- CASE3 THE SLOVAK EXPERIENCE IN THE INTERNATIONAL PRICE BENCHMARKING FOR PRESCRIPTION DRUGSValue in Health, 2009
- Access to Medicines and the Innovation Dilemma — Can Pharmaceutical Multinationals be Good Corporate Citizens?2007
- A pricing policy towards the sourcing of cheaper drugs in CyprusHealth Policy, 2007
- Pharmaceutical promotion and GP prescription behaviourHealth Economics, 2005
- The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990sHealth Economics, 2004
- The Pharmaceutical Industry — Prices and ProgressNew England Journal of Medicine, 2004
- Cross-national price differences for pharmaceuticals: how large, and why?Journal of Health Economics, 2000
- Health policy versus industrial policy in the pharmaceutical sector: the case of CanadaHealth Policy, 1997
- PRICE ELASTICITY AND ADVERSE SELECTION IN THE DEMAND FOR SUPPLEMENTARY HEALTH INSURANCEEconomic Inquiry, 1987